Compare LDOS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LDOS | DGX |
|---|---|---|
| Founded | 1969 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9B | 20.5B |
| IPO Year | 2006 | 1996 |
| Metric | LDOS | DGX |
|---|---|---|
| Price | $186.61 | $182.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | ★ $204.91 | $194.07 |
| AVG Volume (30 Days) | 751.8K | ★ 1.2M |
| Earning Date | 11-04-2025 | 10-21-2025 |
| Dividend Yield | 0.92% | ★ 1.75% |
| EPS Growth | ★ 22.34 | 14.49 |
| EPS | ★ 10.68 | 8.51 |
| Revenue | ★ $17,332,000,000.00 | $10,850,000,000.00 |
| Revenue This Year | $5.17 | $12.37 |
| Revenue Next Year | $3.59 | $3.52 |
| P/E Ratio | ★ $17.49 | $21.44 |
| Revenue Growth | 6.48 | ★ 13.74 |
| 52 Week Low | $123.62 | $148.70 |
| 52 Week High | $205.77 | $197.55 |
| Indicator | LDOS | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 44.52 | 44.87 |
| Support Level | $186.27 | $184.18 |
| Resistance Level | $196.56 | $185.12 |
| Average True Range (ATR) | 4.19 | 3.22 |
| MACD | -0.23 | -0.78 |
| Stochastic Oscillator | 21.72 | 3.85 |
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.